Part 1: Financial Health of GEVO To assess GEVO's financial health, we use the accounting identity Assets = Liabilities + Equity. Total Assets: $522.74 million Total Liabilities: $70.77 million Equity: $452 million The company is well-capitalized with a healthy equity base. The price-to-book (P/B) ratio is: P/B Ratio = Market Cap Equity = 340.16   M 452   M = 0.75 P/B Ratio= Equity Market Cap ​ = 452M 340.16M ​ =0.75 This P/B ratio indicates the stock is potentially undervalued compared to its book value since a ratio below 1 suggests the market values the company at less than its net asset value. Part 2: Income Statement Analysis Looking at GEVO's income statement: Revenue: $18.15 million (TTM) Net Loss: $74.05 million Operating Loss: $89.23 million GEVO has faced ongoing net losses, and its gross profit is negative, meaning its cost of sales exceeds revenue. Now, calculating the price-to-earnings (P/E) ratio: P/E Ratio = Market Cap Net Profit = 340.16   M − 74.05   M = − 4.59 P/E Ratio= Net Profit Market Cap ​ = −74.05M 340.16M ​ =−4.59 Since GEVO is unprofitable, the P/E ratio is negative, making this metric less relevant for valuation. Part 3: Cash Flow Statement Analysis Operating Cash Flow: -$63.27 million Investing Cash Flow: -$40.63 million Free Cash Flow: -$103.9 million The company has negative free cash flow (FCF), and the price-to-free cash flow (P/FCF) ratio can be calculated as: P/FCF Ratio = Market Cap Free Cash Flow = 340.16   M − 103.9   M = − 3.27 P/FCF Ratio= Free Cash Flow Market Cap ​ = −103.9M 340.16M ​ =−3.27 Conclusion: Overvalued or Undervalued? Given that GEVO has a negative net profit and free cash flow, and is trading below its book value with a P/B ratio of 0.75, it suggests the stock may be undervalued. However, with consistent losses and negative cash flow, the company faces significant financial challenges. Investors should consider these factors before concluding whether the stock is a good value play or a risky investment​